Live attenuated varicella vaccine ANNUAL REVIEW OF MICROBIOLOGY Arvin, A. M., Gershon, A. A. 1996; 50: 59-100

Abstract

Varicella-zoster virus (VZV) is a ubiquitous human pathogen that causes varicella, commonly called chicken pox; establishes latency; and reactivates as herpes zoster, referred to as shingles. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The vaccine induces persistent immunity to VZV in healthy children and adults. Immunization against VZV also has the potential to lower the risk of reactivation of latent virus. The varicella vaccine may eventually reduce or eliminate herpes zoster, which is a serious problem for elderly and immunocompromised individuals.

View details for Web of Science ID A1996VL56000004

View details for PubMedID 8905076